Section Arrow
Quote
DRMA.NASDAQ
- Dermata Therapeutics Inc
Quotes are at least 15-min delayed:2026/03/09 10:16 EDT
Regular Hours
Last
 1.26
+0.02 (+1.61%)
Day High 
1.28 
Prev. Close
1.24 
1-M High
2.29 
Volume 
19.25K 
Bid
1.26
Ask
1.28
Day Low
1.24 
Open
1.25 
1-M Low
1.11 
Market Cap 
3.52M 
Currency 美元 
P/E 0.08 
%Yield -- 
10-SMA 1.21 
20-SMA 1.36 
50-SMA 1.87 
52-W High 23.7 
52-W Low 1.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
15.24/-0.82
Enterprise Value
3.52M
Balance Sheet
Book Value Per Share
1.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio8.38-0.27-3.12%-- 
RLMDRelmada Therapeutics6+1.55+34.83%-- 
QUREuniQure NV16.745+2.505+17.59%-- 
XENEXenon Pharmaceuticals59.44+17.51+41.76%-- 
IOVAIovance Biotherapeutics5.12-0.015-0.29%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.